← Leaderboards
Robert Spitz
Icon Government And Public Health Solutions, Inc.
$3,033,881
Attributed
$3,033,881
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.1M · FY2022–25$2.5M$1.9M$1.3M$625K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,033,881 · 1
By mechanism
N01$3,033,881 · 1
Top collaborators
No co-investigators on record.
Most similar at Icon Government And Public Health Solutions, Inc.
Same institution · by research overlap
- Kristopher Paolino$4,299,774
- Chris Mason$321,691
- J. McLeod Griffiss$3,088,882
- Robert Tibbetts$231,167
- John Griffis$126,942
Others in their field
Other Rising Stars on “Investigation”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Angee Greer · Ppd Development Lp$82,531,927
- Jessica Ellis · Technical Resources International, Inc.$43,038,640
- Rhea Coler · Seattle Children'S Hospital$35,184,139
- Joan Grand · Mitre Corporation$32,826,287
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
Research focus
InvestigationClinical Trials UnitClinical Trial ImplementationEarly Phase Clinical TrialNew AgentsCommunicable DiseasesPreventionNational Institute Of Allergy And Infectious DiseaseClinical TrialsDrug KineticsSafetyPhase I Clinical TrialsTuberculosisMycobacterium TuberculosisClostridium DifficileCombating Antibiotic Resistant BacteriaAntibiotic ResistancePhase I TrialSpecial PopulationStudy PopulationStudy Subject
Grant awards (7)
TASK D10: A PHASE 1 TRIAL TO EVALUATE A TREATMENT FOR CLOSTRIDIOIDES DIFFICILE$370,101
N01 · FY2025 · AI · contact PI
Early Phase Clinical Trial Units (EPCTU)$160,073
N01 · FY2025 · AI · contact PI
Task A: Early Phase Clinical Trial Units (EPCTU)$164,056
N01 · FY2024 · AI · contact PI
Task C1D1: A Study to Evaluate the Pharmacokinetics and Safety of a Therapeutic for Antibiotic-Resistant Tuberculosis$59,004
N01 · FY2024 · AI · contact PI
EPCTU: A Study to Evaluate the Pharmacokinetics and Safety of a Therapeutic for Tuberculosis$1,962,150
N01 · FY2023 · AI · contact PI
Early Phase Clinical Trial Unit$157,685
N01 · FY2023 · AI · contact PI
Early Phase Clinical Trial Unit$160,812
N01 · FY2022 · AI · contact PI